vs

Side-by-side financial comparison of SPS COMMERCE INC (SPSC) and Zai Lab Ltd (ZLAB). Click either name above to swap in a different company.

SPS COMMERCE INC is the larger business by last-quarter revenue ($192.7M vs $127.1M, roughly 1.5× Zai Lab Ltd). On growth, Zai Lab Ltd posted the faster year-over-year revenue change (17.1% vs 12.7%). SPS COMMERCE INC produced more free cash flow last quarter ($38.2M vs $-26.7M). Over the past eight quarters, Zai Lab Ltd's revenue compounded faster (20.8% CAGR vs 13.5%).

SPS Commerce, Inc. is a technology and application software company based in the United States that provides cloud-based supply chain management software. The company's headquarters are located in Minneapolis, Minnesota, but it also has a US office in New Jersey, and international locations in Amsterdam, Beijing, Breukelen, Hong Kong, Kyiv, Melbourne, Montpellier, Sydney, and Toronto.

Zai Lab Ltd is a global biopharmaceutical company focused on developing, manufacturing and commercializing innovative therapies for oncology, autoimmune disorders, infectious diseases and other unmet medical needs. It operates primarily in the Greater China region and partners with leading global biotech firms to expand access to life-saving treatments for underserved patient populations.

SPSC vs ZLAB — Head-to-Head

Bigger by revenue
SPSC
SPSC
1.5× larger
SPSC
$192.7M
$127.1M
ZLAB
Growing faster (revenue YoY)
ZLAB
ZLAB
+4.4% gap
ZLAB
17.1%
12.7%
SPSC
More free cash flow
SPSC
SPSC
$64.9M more FCF
SPSC
$38.2M
$-26.7M
ZLAB
Faster 2-yr revenue CAGR
ZLAB
ZLAB
Annualised
ZLAB
20.8%
13.5%
SPSC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
SPSC
SPSC
ZLAB
ZLAB
Revenue
$192.7M
$127.1M
Net Profit
$25.8M
Gross Margin
70.4%
51.0%
Operating Margin
18.0%
-54.6%
Net Margin
13.4%
Revenue YoY
12.7%
17.1%
Net Profit YoY
47.2%
EPS (diluted)
$0.69
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SPSC
SPSC
ZLAB
ZLAB
Q4 25
$192.7M
$127.1M
Q3 25
$189.9M
$115.4M
Q2 25
$187.4M
$109.1M
Q1 25
$181.5M
$105.7M
Q4 24
$170.9M
$108.5M
Q3 24
$163.7M
$101.8M
Q2 24
$153.6M
$100.1M
Q1 24
$149.6M
$87.1M
Net Profit
SPSC
SPSC
ZLAB
ZLAB
Q4 25
$25.8M
Q3 25
$25.6M
$-36.0M
Q2 25
$19.7M
$-40.7M
Q1 25
$22.2M
$-48.4M
Q4 24
$17.6M
Q3 24
$23.5M
$-41.7M
Q2 24
$18.0M
$-80.3M
Q1 24
$18.0M
$-53.5M
Gross Margin
SPSC
SPSC
ZLAB
ZLAB
Q4 25
70.4%
51.0%
Q3 25
69.5%
59.5%
Q2 25
68.1%
60.6%
Q1 25
68.7%
63.6%
Q4 24
67.5%
61.5%
Q3 24
68.5%
64.1%
Q2 24
66.1%
64.9%
Q1 24
65.6%
61.4%
Operating Margin
SPSC
SPSC
ZLAB
ZLAB
Q4 25
18.0%
-54.6%
Q3 25
16.4%
-42.3%
Q2 25
14.1%
-50.3%
Q1 25
14.3%
-53.3%
Q4 24
14.5%
-62.6%
Q3 24
15.6%
-66.6%
Q2 24
15.1%
-76.0%
Q1 24
10.3%
-80.7%
Net Margin
SPSC
SPSC
ZLAB
ZLAB
Q4 25
13.4%
Q3 25
13.5%
-31.2%
Q2 25
10.5%
-37.3%
Q1 25
12.2%
-45.8%
Q4 24
10.3%
Q3 24
14.3%
-40.9%
Q2 24
11.7%
-80.2%
Q1 24
12.0%
-61.4%
EPS (diluted)
SPSC
SPSC
ZLAB
ZLAB
Q4 25
$0.69
$-0.05
Q3 25
$0.67
$-0.03
Q2 25
$0.52
$-0.04
Q1 25
$0.58
$-0.04
Q4 24
$0.46
$-0.09
Q3 24
$0.62
$-0.04
Q2 24
$0.48
$-0.08
Q1 24
$0.48
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SPSC
SPSC
ZLAB
ZLAB
Cash + ST InvestmentsLiquidity on hand
$151.4M
$689.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$973.9M
$715.5M
Total Assets
$1.2B
$1.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SPSC
SPSC
ZLAB
ZLAB
Q4 25
$151.4M
$689.6M
Q3 25
$133.7M
$717.2M
Q2 25
$107.6M
$732.2M
Q1 25
$94.9M
$757.3M
Q4 24
$241.0M
$779.7M
Q3 24
$205.8M
$616.1M
Q2 24
$271.8M
$630.0M
Q1 24
$290.8M
$650.8M
Stockholders' Equity
SPSC
SPSC
ZLAB
ZLAB
Q4 25
$973.9M
$715.5M
Q3 25
$958.9M
$759.9M
Q2 25
$949.8M
$791.7M
Q1 25
$920.9M
$810.8M
Q4 24
$854.7M
$840.9M
Q3 24
$829.4M
$667.7M
Q2 24
$703.4M
$704.2M
Q1 24
$683.0M
$762.2M
Total Assets
SPSC
SPSC
ZLAB
ZLAB
Q4 25
$1.2B
$1.2B
Q3 25
$1.2B
$1.2B
Q2 25
$1.1B
$1.2B
Q1 25
$1.1B
$1.2B
Q4 24
$1.0B
$1.2B
Q3 24
$1.0B
$985.3M
Q2 24
$854.5M
$987.4M
Q1 24
$839.8M
$988.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SPSC
SPSC
ZLAB
ZLAB
Operating Cash FlowLast quarter
$45.9M
$-26.0M
Free Cash FlowOCF − Capex
$38.2M
$-26.7M
FCF MarginFCF / Revenue
19.8%
-21.0%
Capex IntensityCapex / Revenue
4.0%
0.5%
Cash ConversionOCF / Net Profit
1.78×
TTM Free Cash FlowTrailing 4 quarters
$152.3M
$-158.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SPSC
SPSC
ZLAB
ZLAB
Q4 25
$45.9M
$-26.0M
Q3 25
$60.6M
$-32.0M
Q2 25
$32.3M
$-31.0M
Q1 25
$40.0M
$-61.7M
Q4 24
$40.6M
$-55.8M
Q3 24
$53.3M
$-26.8M
Q2 24
$29.4M
$-42.2M
Q1 24
$34.1M
$-90.1M
Free Cash Flow
SPSC
SPSC
ZLAB
ZLAB
Q4 25
$38.2M
$-26.7M
Q3 25
$54.6M
$-35.0M
Q2 25
$25.7M
$-33.9M
Q1 25
$33.8M
$-63.2M
Q4 24
$34.3M
$-58.4M
Q3 24
$48.1M
$-28.2M
Q2 24
$24.4M
$-42.9M
Q1 24
$30.5M
$-91.1M
FCF Margin
SPSC
SPSC
ZLAB
ZLAB
Q4 25
19.8%
-21.0%
Q3 25
28.7%
-30.4%
Q2 25
13.7%
-31.1%
Q1 25
18.6%
-59.9%
Q4 24
20.1%
-53.8%
Q3 24
29.4%
-27.7%
Q2 24
15.9%
-42.9%
Q1 24
20.4%
-104.5%
Capex Intensity
SPSC
SPSC
ZLAB
ZLAB
Q4 25
4.0%
0.5%
Q3 25
3.2%
2.6%
Q2 25
3.6%
2.6%
Q1 25
3.4%
1.5%
Q4 24
3.6%
2.4%
Q3 24
3.2%
1.3%
Q2 24
3.3%
0.7%
Q1 24
2.4%
1.1%
Cash Conversion
SPSC
SPSC
ZLAB
ZLAB
Q4 25
1.78×
Q3 25
2.37×
Q2 25
1.64×
Q1 25
1.80×
Q4 24
2.31×
Q3 24
2.27×
Q2 24
1.63×
Q1 24
1.89×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

SPSC
SPSC

Recurring Revenues$184.5M96%
One Time Revenues$8.1M4%
Set Up Fees$4.1M2%

ZLAB
ZLAB

Zejula$56.0M44%
Other$21.9M17%
Nuzyra$16.0M13%
Optune$11.9M9%
XACDURO$10.7M8%
Qinlock$9.7M8%
AUGTYRO$836.0K1%

Related Comparisons